Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03600337
Other study ID # 2017-08-0024
Secondary ID 5P30NR015335
Status Completed
Phase N/A
First received
Last updated
Start date June 15, 2018
Est. completion date April 1, 2020

Study information

Verified date December 2020
Source University of Texas at Austin
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder, affecting 7%-18% of reproductive-age women. Women with PCOS are at increased risk for a number of adverse physical and mental health outcomes. Often diagnosed during the challenging developmental period of adolescence (ages 14-18), current clinical practice guidelines fail to consider the life-long nature of effective PCOS self-management through sustained healthy lifestyle habits and may, in fact, contribute to maladaptive patterns of unsustainable strategies for weight loss in adolescents. The investigators are testing an integrated mindfulness-based healthy lifestyle intervention for adolescents with PCOS (Working to Optimize Wellness in Teens with PCOS [WOW]). The purpose of this study is to obtain data supporting preliminary efficacy of WOW on biological and mental health outcomes with adolescents diagnosed with PCOS.


Description:

Innovative approaches to addressing the unique physical and mental health needs of adolescents with PCOS are needed. In response to this need, the investigators have developed an integrated mindfulness-based healthy lifestyle intervention for adolescents with PCOS (Working to Optimize Wellness in Teens with PCOS [WOW] through an iterative process of serial focus groups with adolescents and parents of adolescents with PCOS guided by the Individual and Family Self-Management Theory (IFSMT). In this pilot randomized control trial (RCT), 40 adolescents aged 14-18 years will be recruited to participate in the 5-week Working to Optimize Wellness in Teens with PCOS (WOW) intervention (N=20) or a waitlist-control condition (n=20). All participants will receive treatment as usual. Participants will meet weekly for 75-90 minutes for five weeks. Data collection will occur at 3 time points: Baseline data (T1) will be collected from all participants immediately following the informed consent process, Time 2 (T2) data will be collected immediately post-intervention, and Time 3 (T3) data will be collected one-month post-intervention. The waitlist- control condition will receive the intervention immediately following the one-month post-intervention data collection period. Following completion of the self-report measures at T3, individual exit interviews will be conducted with a subset of participants (N=10) from the WOW condition. The primary aims of this research study are: 1. To conduct a pilot RCT with 40 adolescents (ages 14-18) diagnosed with PCOS comparing WOW (n=20) to a wait-list control condition (n=20), and conduct individual exit-interviews to further refine WOW. The investigators expect to determine: a. Preliminary effects of WOW vs. wait-list control on blood pressure, fasting insulin, hemoglobin A1C, nutrition self-efficacy, physical activity, medication adherence, psychological well-being (i.e., depressive/anxiety symptoms, perceived stress, self-esteem) and health related quality of life.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date April 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 14 Years to 23 Years
Eligibility Inclusion Criteria: - adolescent age 14-23 years, - diagnosis of PCOS, OR obesity AND secondary amenorrhea, OR excessive and frequent menstruation and - ability to provide informed consent. Exclusion Criteria: - inability to commit to attending all intervention sessions - unable to provide written informed consent/assent - loss of a loved one within the last year, or - history of post-traumatic stress disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Working to Optimize Wellness in Tees with PCOS (WOW)
5 week, 75 minutes weekly, integrated mindfulness-based mental and physical health promotion intervention

Locations

Country Name City State
United States University of Texas at Austin Austin Texas

Sponsors (3)

Lead Sponsor Collaborator
University of Texas at Austin Fordham University, National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in psychological distress The Depression, Anxiety, and Stress Scale is a 21-item standardized scale that assess symptoms of depression, anxiety, and perceived stress. Participants rate each item from 0=Did not apply to me at all to 3=Applied to me very much or most of the time. All items are summed for a possible range from 0-63 with higher scores indicating higher levels of psychological distress. Immediately post-intervention
Primary Change in health related quality of life The Child Health Questionnaire-Child Self-Report Form is an 87-item measure consisting of 12 summed subscales assessing unique physical and psychosocial domains. Items are scored from 0 to 100 with higher scores indicating better quality of life Immediately post-intervention
Secondary Change in Diet self-efficacy The Diet Self-Efficacy Scale is an 11-item standardized measure assessing self-efficacy for healthy nutrition choices in three domains, (a) high caloric food temptation, (b) social and internal factors, and (c) negative emotional events. For each item, participants select their level of confidence from 0=Not at all confident to 4= Very confident. Item scores are summed for a possible score range from 0 (very little diet self-efficacy) to 44 (very high diet self-efficacy). Immediately post-intervention, 1-month post-intervention
Secondary Change in Physical activity self-efficacy The PACE Adolescent Physical Activity Survey is a 50-item standardized measure that assesses adolescents' stage of change, self-efficacy, family support, and peer support for physical activity. Self-efficacy is assessed with 7 items rated from 1=I'm sure I can't to 5=I'm sure I can. The mean of these 7 items will be used to assess physical activity self-efficacy immediately post-intervention and again at 1-month post-intervention with a possible score range from 1 to 7 and higher scores indicating higher self-efficacy for physical activity. Immediately post-intervention, 1-month post-intervention
Secondary Change in self-esteem The Rosenberg Self-Esteem Scale is a 10-item scale that measures an individual's self-esteem. Participants rate each item from 3=Strongly Agree to 0=Strongly Disagree. Scores for the 10 items are summed for a possible score from 0 to 40 with higher scores indicating higher self-esteem. Immediately post-intervention
See also
  Status Clinical Trial Phase
Recruiting NCT06101147 - Effect of Vitamin D Supplementation on Testosterone Level in Women With Polycystic Ovary Syndrome Phase 2
Completed NCT02037672 - PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome Phase 4
Completed NCT01833949 - Unilateral Laparoscopic Diathermy Adjusted to Ovarian Volume N/A
Completed NCT03608813 - Myo-inositol, D-chiro-inositol and Glucomannan in PCOS
Not yet recruiting NCT05298657 - The Angiotensin-Melatonin Axis in Poor and Hyper Responders for IVF Treatment
Completed NCT05951309 - Myoinositol Treatment and Asprosin Levels in PCOS N/A
Enrolling by invitation NCT04485403 - The Effect of Ibuprofen on Women With PCOS. Phase 2
Not yet recruiting NCT03978013 - Pomegranate Juice Effect on Oxidative Stress in Infertile Women During IVF Treatment N/A
Recruiting NCT03767569 - Myo-inositol as Pretreatment in Hyperandrogenic PCOS Patients Phase 3
Completed NCT05843955 - Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Recruiting NCT05971849 - Dampening the Reproductive Axis With Continuous Kisspeptin Phase 1
Recruiting NCT04597099 - Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion Early Phase 1
Active, not recruiting NCT05206448 - Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation Phase 4
Recruiting NCT02358421 - Prediction of High Ovarian Response After Assisted Reproductive Techniques N/A
Completed NCT04113889 - Effects of Triple Drug Cocktail Therapy on Metabolic, Endocrine Alterations and Perceived Stress in Patients With Poly Cystic Ovary Syndrome Phase 2
Completed NCT04562883 - Single vs. Group CAPA-IVM Culture of Cumulus-oocyte Complexes N/A
Recruiting NCT03264638 - A Clinical and Biological Research of Combined Chinese and Western Medicine in the Treatment of PCOS Phase 2
Completed NCT00594217 - Determining How Quickly Progesterone Slows LH Pulse Frequency Phase 1
Recruiting NCT02024984 - Luteal Phase Versus Follicular Phase Administration of Clomiphene Citrate in PCOS, A Randomized Controlled Trial Phase 1
Completed NCT01709942 - Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) Phase 3